IP Library Granted Patent US 8,071,723
Granted Patent B2
US 8,071,723 · App. 12/153,956 · Granted Dec 6, 2011

Stable D-dimer liquid preparation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,071,723
App. No.
12/153,956
Granted
Dec 6, 2011
Kind
B2
Abstract

The invention is in the field of coagulation diagnosis and relates to a liquid, buffer-based D-dimer composition, which additionally contains fibrinogen and which is suitable as a standard material for control or calibration purposes for D-dimer test procedures.

Claims (17)

1. A stable D-dimer composition comprising a mixture comprising a buffer, D-dimer, and fibrinogen, wherein the stable D-dimer composition comprises fibrinogen in a concentration of more than about 0.025 g/l to at most about 2.5 g/l, and wherein the stable D-dimer composition is obtained by incubating said mixture at about 30° C. to about 50° C.

2. The stable D-dimer composition of claim 1 , wherein the fibrinogen is human or animal fibrinogen.

3. The stable D-dimer composition of claim 1 , wherein the fibrinogen concentration is about 0.1 g/l to about 1 g/l.

4. The stable D-dimer composition of claim 1 , wherein the fibrinogen concentration is about 0.2 g/l to about 0.5 g/l.

5. The stable D-dimer composition of claim 1 , wherein the composition is liquid.

6. The stable D-dimer composition of claim 1 , wherein the composition comprises about 0.1 to about 100 mg/l fibrinogen equivalent unit (FEU) D-dimer.

7. The stable D-dimer composition of claim 1 , which additionally comprises an inert protein, and/or a protease inhibitor and/or a detergent and/or an additive having bactericidal and/or fungicidal action.

8. The stable D-dimer composition of claim 7 , wherein the inert protein comprises bovine serum albumin.

9. The stable D-dimer composition of claim 7 , wherein the additive having bactericidal and/or fungicidal action comprises sodium azide.

10. The stable D-dimer composition of claim 1 , wherein the composition comprises about 0 to at most about 10 percent by volume of clot lysis plasma.

11. The stable D-dimer composition of claim 10 , wherein the buffer comprises at most about 5 percent by volume of clot lysis plasma.

12. The stable D-dimer composition of claim 11 , wherein the buffer comprises at most about 1 percent by volume of clot lysis plasma.

13. The stable D-dimer composition of claim 12 , wherein the buffer comprises at most about 0.5 percent by volume of clot lysis plasma.

14. The stable D-dimer composition claim 1 , wherein the mixture is incubated at about 37° C.

15. The stable D-dimer composition claim 1 , wherein the mixture is incubated at about 30° C. to about 50° C. for 4 hours to 7 days.

16. The stable D-dimer composition claim 15 , wherein the mixture is incubated for 12 hours to 3 days.

17. The stable D-dimer composition claim 1 , wherein the stable D-dimer composition is a D-dimer calibrator and/or control composition.

Assignments (2)
CHANGE OF NAME Recorded Feb 26, 2009
From: DADE BEHRING MARBURG GMBH
To: SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
Reel/Frame 022309/0627 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 8, 2008
From: PILGRIM, SABINE; ZANDER, NORBERT
To: DADE BEHRING MARBURG GMBH
Reel/Frame 021390/0534 →